Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspirone and citalopram effects on perceptual rivalry switch rate
ACTRN12611000084987Phase 4Recruiting
- Sponsor
- University of Melbourne
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of buspirone and citalopram (4 arms), sponsored by University of Melbourne. Primary endpoint: Binocular rivalry switch rate. Started Mar 2011; status: recruiting.
02
Drugs
buspironecitalopram
Beyond the preview
Go deeper on ACTRN12611000084987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000084987.